Figure 1
From: Decreased expression of LATS1 is correlated with the progression and prognosis of glioma
The reduced expression levels of LATS1 mRNA and protein in glioma and Kaplan–Meier plots of overall survival duration in patients with glioma. A. LATS1 mRNA level was markedly downregulated in glioma samples compared to their matched normal brain tissues. B. Reduced protein expression of LATS1 in glioma. 1: Strong expression of LATS1 in normal brain; 2: Strong expression of LATS1 in glioma WHO grade-1; 3: Strong expression of LATS1 in glioma WHO grade-2; 4: Weak expression of LATS1 in glioma WHO grade-3. 5. Negative expression of LATS1 in glioma WHO grade-4; C. Kaplan–Meier survival analysis of overall survival duration in 103 glioma patients according to LATS1 protein expression. The log-rank test was used to calculate p values.